Latest News

  • Is The Molecular Diagnostics Industry Ready For NGS?

    Diagnostics World | Elena Grigorenko, VP of research and development at Diaterics, talks about what happens when science outpaces reimbursement, how to develop and validate a genetic drug resistance panel, and whether the industry is ready for next-generation sequencing.

    Jul 25, 2017
  • Implementing Point-Of-Care Testing And Pharmacogenetic Testing In The Community Pharmacy

    Diagnostics World Brief | Edana Holliday of Rx Clinic Pharmacy is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Holliday speaks about how Rx Clinic Pharmacy is working to integrate point-of-care testing and pharmacogenetic testing into their practice, and how use of these methods can bring doctors and pharmacists into new collaborations.

    Jul 21, 2017
  • FDA Clears First MRI Meant for Use in NICUs

    RAPS | The US Food and Drug Administration has cleared an MRI device intended to be used on newborns in the neonatal intensive care unit. Traditional MRIs can be used on babies, but usually require transferring them out of NICU. The new device can be placed inside the NICU.

    Jul 20, 2017
  • Why Couldn’t This Man Stop Hiccupping?

    The New York Times | Diagnostic tools were used to solve the case of a man's combination of hiccups and odd neurological symptoms.

    Jul 20, 2017
  • AliveCor, Mayo Clinic Partner On Long QT Diagnostic

    Diagnostics World Brief  AliveCor and the Mayo Clinic today announced a collaboration to develop tools for medical and non-medical personnel to easily screen for long QT syndrome (LQTS), a heart rhythm condition that can cause rapid heartbeats. AliveCor plans to combine its AI technology with Mayo’s patented algorithms to detect LQTS early.

    Jul 19, 2017
  • First Slice Of Long-Term 100K Study: Useful Data, No Health Outcomes

    Xconomy | A small study in Seattle called the Pioneer 100 Wellness Project, published in the August issue of Nature Biotechnology, aims to build evidence that comprehensive testing of healthy people can stave off disease. Study leaders include genomics pioneer Leroy “Lee” Hood, who for years has pushed for a data-intensive form of healthcare described with four P’s: predictive, preventive, personalized, and participatory.

    Jul 18, 2017
  • Heidi Rehm Calls For Sharing of Variant Interpretation Data

    Diagnostics World | In an invited commentary published on Friday in Genetics in Medicine, Heidi Rehm outlines the state of variant interpretation, and makes a call to the community to share variant interpretation data. “I… put out a plea to the community to step up and take action to ensure transparency in variant interpretation, to allow laboratories to subject their interpretations to peer review by the community, and to enable aggregation of evidence to improve knowledge over time,” she writes.

    Jul 17, 2017
  • Teladoc Completes Acquisition Of Best Doctors

    Diagnostics World Brief | Teladoc today announced the completion of its acquisition of Best Doctors, the world’s leading expert medical consultation company focused on improving health outcomes for the most complex, critical, and costly medical issues.

    Jul 17, 2017
  • NHS Hospitals Could Get DNA Readers Within Five Years As Trials Begin

    The Telegraph | A trial for the identification and treatment of hospital-acquired pneumonia is starting in the UK. The trial will pit Oxford Nanopore's MinION reader against two other non-sequencing genetic tests. The goal is to accurately and quickly identify the bacteria causing pneumonia, so the right antibiotic can be prescribed.

    Jul 13, 2017
  • Metal-Free MRI Contrast Agent Could Be Safer For Some Patients

    MIT News | Researchers from MIT and the University of Nebraska have developed a metal-free MRI contrast agent that could be safer for certain patients. The compound contains organic molecules called nitroxides instead of metal and may be used to generate more informative MRI scans of tumors.

    Jul 13, 2017
  • Nestle invests in microbiome-based diagnostics venture

    Reuters | Food group Nestle's (NESN.S) health science business is investing 20 million euros ($22.8 million) in a joint venture with pharma and diagnostics company Enterome SA to develop microbiome-based diagnostics for inflammatory bowel and liver diseases, Enterome said on Tuesday.

    Jul 12, 2017
  • Precision Medicine Outside Of Oncology

    Diagnostics World Brief | Jonathan Pan of Aevi Genomic Medicine is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include precision medicine outside of oncology, unique genomic approaches, implementation in routine care, and more.

    Jul 11, 2017
  • Chemotherapy Before Breast Cancer Surgery Might Fuel Metastasis

    STAT | When breast cancer patients get chemotherapy before surgery, it can make remaining malignant cells spread to distant sites, a new study found.

    Jul 10, 2017
  • Walking Down Evidence Street: Where The Market Meets Evidence

    Diagnostics World Brief | Suzanne Belinson of Blue Cross Blue Shield Association is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include using web-based platform where stakeholders can view evidence, if we need more standardized requirements for payers and regulators, and hopes for the conference.

    Jul 5, 2017